The Positives
Spike up in V-liver revenue.
- Read more at SGinvestors.io.
17LIVE (SGX:LVR)
Above is an excerpt from a report by Phillip Securities Research.
Clients of Phillip Capital may be the first to access the full PDF report @ https://www.stocksbnb.com/.
Read also Phillip's most recent report:
2026-01-30 17Live Group - Removing Exclusivity To Unlock Liver Monetisation.
Previous report by Phillip:
2025-10-13 17LIVE Group - Growth From Cash Cow Businesses.
Price targets by other brokers at 17LIVE Target Prices.
Listing of research reports at 17LIVE Analyst Reports.
Relevant links:
17LIVE Share Price History,
17LIVE Announcements,
17LIVE Dividend Payout Dates & Corporate Actions,
17LIVE News